Business Wire

Meitheal Pharmaceuticals Secures Exclusive Commercial Licensing Agreement for Three Biosimilars in the U.S.

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
Business Wire

Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics

CHICAGO--(BUSINESS WIRE)--Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago and focused on the development and commercialization of generic ...
Mandurah Mail

Trial to reshape 'gruelling, traumatic' IVF process

A Victorian-first study into a gentler IVF treatment hopes to reshape fertility care by eliminating the two-week ...
Benzinga.com

Celmatix Nominates First Lead Compound in Oral Fertility Drug Program

Dr. Piraye Yurttas Beim, Founder and CEO of Celmatix, stated, "Our oral FSH program stands to fundamentally change the landscape of fertility treatments. By offering a non-invasive alternative to ...